Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Fisher Healthcare™ Sure-Vue™ RPR Antigen Suspension
Sure-Vue’s non-treponemal RPR antigen screens for syphilis; a sexually transmitted disease caused by the bacterium Treponema pallidum (a spirochete bacteria). The disease is found worldwide and is easily treated if detected early. This test is FDA cleared for use in diagnostic screening.
Catalog No. 23-038011
This item is not returnable.
View return policy
Description
- CLIA Complexity: Non-Waived
- CPT Codes: 86542/86593
- Cardiolipin charcoal microparticle test for the qualitative and semi-quantitative determination of reagin, which is associated with syphilis
- Antigen detects 'reagin' present in serum of syphilitic patients
- Test results in eight minutes
- Positive results yield a flocculation of the antigen; negative results yield no reaction and a gray homogeneous suspension, or a button of non-aggregating carbon particles in the center of the circle
- For in vitro diagnostic use
- Contains Sodium Azide 0.1%
Specifications
| RPR Antigen Suspension | |
| Moderate (Serum, Plasma or Whole Blood), Waived (Other) | |
| RPR Antigen Suspension | |
| For in-vitro diagnostic use | |
| Ready-to-Use (RTU) |
| Self-declared | |
| Reagin (Syphilis) | |
| Single-use | |
| 1 x 9 mL |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction